Biomea Fusion, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
BMEA on Nasdaq
Industry
Pharmaceutical Preparations
Location
900 Middlefield Road, 4 Th Floor, Redwood City, CA

Insiders trading volume in the past year

Biomea Fusion, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sotirios Stergiopoulos Director $16.6M Sep 17, 2021
Bihua Chen Director, 10%+ Owner $15.8M Jun 12, 2024
A2A Pharmaceuticals, Inc. 10%+ Owner $13.2M May 31, 2023
Rainer M. Erdtmann President and COO, Director $3.73M Jan 17, 2024
Franco Valle Chief Financial Officer $265K +$55.4K +26.5% Nov 30, 2024
Michael J.M. Hitchcock Interim CEO, Director $151K +$101K +200% Mar 26, 2025
Juan Pablo Frias Chief Medical Officer $3.12K May 31, 2024
Elizabeth Faust Director Jun 12, 2024
Eric Aguiar Director Jun 12, 2024
Biomea Health, LLC 10%+ Owner Jun 1, 2022
Sumita Ray Director Jun 12, 2024
Thomas Andrew Butler Chief Executive Officer, Director, 10%+ Owner Jan 17, 2024

Recent Insider Transactions by Companies or Individuals for Biomea Fusion, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.